no image available Dickens & Co. "Breakthrough in Leukemia Treatment: FDA Approves Mogamulizumab for Relapsed Aggressive Lymphoma" "A New Hope for Patients with Relapsed Cutaneous T-Cell Lymphoma: The Journey of Mogamulizumab from Lab to Clinic" Price: 19.00€